Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | +94.23% | $235.95 | $458.28 | 2025-01-07 - 2025-08-19 | Buy |
Vertex Pharmaceuticals IncVRTX | +41.12% | $358.40 | $505.78 | 2023-08-02 - 2024-08-01 | Buy |
Vertex Pharmaceuticals IncVRTX | +39.88% | $354.05 | $495.26 | 2023-07-28 - 2024-07-26 | Buy |
Vertex Pharmaceuticals IncVRTX | +36.16% | $302.66 | $412.11 | 2023-03-21 - 2024-03-20 | Buy |
Vertex Pharmaceuticals IncVRTX | +15.53% | $346.36 | $400.16 | 2023-05-03 - 2024-05-02 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 1 | Hold | $13.00 | -35.58% | Initiates Coverage On | 22 days ago |
Alnylam Pharmaceuticals IncALNY | 2 | Buy | $310.00 | -32.36% | Maintains | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Buy | $1,070.00 | +87.13% | Maintains | 7 months ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Hold | $24.00 | +20.85% | Maintains | 9 months ago |
Biohaven LtdBHVN | 2 | Buy | $66.00 | +332.79% | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $90.00 | +57.04% | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 4 | Buy | $390.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $54.00 | N/A | Initiates Coverage On | 2 years ago |
Beam Therapeutics IncBEAM | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Hold | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $44.00 | N/A | Initiates Coverage On | 2 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Sell | $31.00 | N/A | Initiates Coverage On | 2 years ago |